Ember Therapeutics (Ember Therapeutics) Total Equity : $-0.25 Mil (As of Sep. 2015)

View and export this data going back to 2015. Start your Free Trial

What is Ember Therapeutics Total Equity?

Ember Therapeutics's total equity for the quarter that ended in Sep. 2015 was $-0.25 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Ember Therapeutics Total Equity Historical Data

The historical data trend for Ember Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ember Therapeutics Total Equity Chart

Ember Therapeutics Annual Data

Trend

Dec12

Dec13

Dec14

Total Equity

-0.20

-0.22

-0.24

Ember Therapeutics Quarterly Data
	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Total Equity	Get a 7-Day Free Trial							-0.23	-0.24	-0.24	-0.25	-0.25

Ember Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Ember Therapeutics's Total Equity for the fiscal year that ended in Dec. 2014 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2014 )	-	Total Liabilities(Q: Dec. 2014 )
	=	N/A	-	0.239
	=	N/A

Ember Therapeutics's Total Equity for the quarter that ended in Sep. 2015 is calculated as

Total Equity	=	Total Assets(Q: Sep. 2015 )	-	Total Liabilities(Q: Sep. 2015 )
	=	0.002	-	0.255
	=	-0.25

Ember Therapeutics Total Equity Related Terms

Thank you for viewing the detailed overview of Ember Therapeutics's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ember Therapeutics (Ember Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ember Therapeutics Inc (OTCPK:EMBT) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

135 East 57th Street, 24th Floor, New York, NY, USA, 10022

Website

http://www.embertx.com

Ember Therapeutics Inc is engaged in the healthcare sector. It is a biopharmaceutical company whose primary focus is on utilizing Bone Morphogenetic Protein-7 (BMP-7) and related family of BMPs, mutants, variants, novel formulations, and delivery technologies. It looks to develop regenerative medicines for disease modification of osteoarthritis, reversal of insulin resistance, and the inhibition and reversal of organ fibrosis in diseases such as chronic kidney disease and Alport Syndrome.

Ember Therapeutics (Ember Therapeutics) Headlines

From GuruFocus

Ember Therapeutics, Inc. Announces Filing of Form 15 to Deregister its Common Stock

By PRNewswire PRNewswire • 10-02-2018